gemfibrozil has been researched along with Jaundice, Neonatal in 1 studies
Jaundice, Neonatal: Yellow discoloration of the SKIN; MUCOUS MEMBRANE; and SCLERA in the NEWBORN. It is a sign of NEONATAL HYPERBILIRUBINEMIA. Most cases are transient self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) occurring in the first week of life, but some can be a sign of pathological disorders, particularly LIVER DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gemfibrozil was not associated with any side effects." | 2.74 | Gemfibrozil in late preterm and term neonates with moderate jaundice: a randomized controlled trial. ( Kumar, P; Narang, A, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, P | 1 |
| Narang, A | 1 |
1 trial available for gemfibrozil and Jaundice, Neonatal
| Article | Year |
|---|---|
Gemfibrozil in late preterm and term neonates with moderate jaundice: a randomized controlled trial.
Topics: Bilirubin; Chi-Square Distribution; Double-Blind Method; Gemfibrozil; Glucosephosphate Dehydrogenase | 2009 |